Ultimate Longevity Bible

Researcher

David Sinclair

Last updated Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)· 3 min read

Background

David Sinclair is Professor of Genetics at Harvard Medical School and co-director of the Paul F. Glenn Center for Biology of Aging Research. He trained at the University of New South Wales in Australia and did postdoctoral work with Lenny Guarente at MIT on yeast sirtuin biology in the late 1990s.

Lines of work

Sirtuin biology

Sinclair’s graduate and postdoctoral work helped establish the sirtuin–ageing hypothesis: that the conserved sirtuin enzymes link metabolic state (via NAD+) to chromatin and stress responses, with implications for lifespan. Many specifics of this story have been revised — the original SIRT1-resveratrol activation assay turned out to be a fluorophore artifact — but the broader role of sirtuins in aging biology remains active research.

NAD+ metabolism

Characterisation of age-related NAD+ decline and the rationale for NAD+ precursor supplementation. Several lab papers tied falling NAD+ to mitochondrial and stem-cell decline in mice and proposed precursor supplementation as a counter.

Information theory of aging

Sinclair’s framing of aging as loss of epigenetic information that can in principle be restored. The 2020 Nature paper (Lu et al.) on partial Yamanaka-factor reprogramming restoring vision in mouse models of glaucoma is the central piece of evidence he cites. See information theory for the broader framework.

Partial reprogramming

Use of OSK (Oct4, Sox2, Klf4 — without c-Myc) delivered by AAV to restore retinal ganglion cell function. Drove much of the current biotech investment in partial-reprogramming approaches (Altos Labs, Life Biosciences, Turn.bio).

Notable papers

  • Lu et al. 2020 (Nature): partial OSK reprogramming restored vision in glaucoma mouse model.
  • Imai, Armstrong, Kaeberlein, Guarente 2000 (PMID 10693807): founding paper on Sir2 as an NAD+-dependent deacetylase (lab-mate paper from Guarente group).
  • Howitz et al. 2003 (Nature): the original resveratrol-SIRT1 paper that launched the STAC field; some conclusions later revised due to assay artifacts.
  • Mills et al. 2016 (PMID 28068222): NMN administration mitigates age-associated physiological decline in mice.

Public profile

One of the most publicly visible longevity researchers. Authored Lifespan (2019) and co-hosts a podcast. Frequent media interviews and conference keynotes.

How to read his public claims

Sinclair’s academic publications go through peer review. Some of his public statements (typical-American-lifespan claims, biological-age reversal timelines, supplement-effect framings) have been criticised by other geroscientists as running ahead of the published evidence. When you encounter a strong claim:

  • Find the underlying primary paper.
  • Check whether the headline framing matches the paper’s conclusions and limitations sections.
  • Note that mouse work doesn’t automatically translate.
  • Compare with positions from more reserved voices in the field (Brian Kennedy, Linda Partridge, Rich Miller, Matt Kaeberlein).

Affiliations & disclosures

Co-founder, scientific advisor, or board member of multiple biotech companies including Sirtris (acquired by GSK, now closed), Life Biosciences, Elysium Health, and others. Significant equity / royalty interests around NAD+-precursor products and sirtuin-targeted compounds. Conflicts are disclosed in his peer-reviewed publications.

Notable trainees / collaborators

  • Trained or co-mentored numerous productive geroscience PIs.
  • Long-running collaborations with Manuel Serrano, Eduard Casanova, Vadim Gladyshev, and others.

Related entries

Information theory of aging, Sirtuins, NAD+ precursors, Partial reprogramming, Lifespan (book), Altos Labs.

References

  • Lu, Y. et al. Reprogramming to recover youthful epigenetic information and restore vision. Nature 588, 124–129 (2020).
  • Sinclair, D. A. & LaPlante, M. D. Lifespan: Why We Age — and Why We Don't Have To. Atria Books (2019).
  • Howitz, K. T. et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191–196 (2003).

More researchers